These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9776172)

  • 1. The use of transgenic animals in research.
    Heddle JA
    Environ Mol Mutagen; 1998; 32(2):110-4. PubMed ID: 9776172
    [No Abstract]   [Full Text] [Related]  

  • 2. Transgenic animal models for mutagenesis studies: role in mutagenesis research and regulatory testing.
    MacGregor JT
    Environ Mol Mutagen; 1998; 32(2):106-9. PubMed ID: 9776171
    [No Abstract]   [Full Text] [Related]  

  • 3. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
    Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
    Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
    Allay E; Veigl M; Gerson SL
    Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of 17beta-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats.
    Han BS; Fukamachi K; Takasuka N; Ohnishi T; Maeda M; Yamasaki T; Tsuda H
    Carcinogenesis; 2002 Jul; 23(7):1209-15. PubMed ID: 12117780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mutation models: research, testing, and reality checks.
    Skopek TR
    Environ Mol Mutagen; 1998; 32(2):104-5. PubMed ID: 9776170
    [No Abstract]   [Full Text] [Related]  

  • 7. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens.
    Naiki-Ito A; Asamoto M; Hokaiwado N; Takahashi S; Yamashita H; Tsuda H; Ogawa K; Shirai T
    Cancer Res; 2007 Dec; 67(23):11353-8. PubMed ID: 18056462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice.
    Qing WG; Conti CJ; LaBate M; Johnston D; Slaga TJ; MacLeod MC
    Carcinogenesis; 1997 Mar; 18(3):553-9. PubMed ID: 9067556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal endbuds and acini as the respective major targets for chemical and sporadic carcinogenesis in the mammary glands of human c-Ha-ras protooncogene transgenic rats.
    Hamaguchi T; Matsuoka Y; Kawaguchi H; Fukamachi K; Takasuka N; Ueda S; Shimizu K; Ohki M; Kusunoki M; Sakakura T; Yoshida H; Tsuda H
    Breast Cancer Res Treat; 2004 Jan; 83(1):43-56. PubMed ID: 14997054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of DNA repair in carcinogen-induced ras mutation.
    Engelbergs J; Thomale J; Rajewsky MF
    Mutat Res; 2000 May; 450(1-2):139-53. PubMed ID: 10838139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.
    Zarbl H; Sukumar S; Arthur AV; Martin-Zanca D; Barbacid M
    Nature; 1985 May 30-Jun 5; 315(6018):382-5. PubMed ID: 3923365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental carcinogens and p53 tumor-suppressor gene interactions in a transgenic mouse model for mammary carcinogenesis.
    Medina D; Ullrich R; Meyn R; Wiseman R; Donehower L
    Environ Mol Mutagen; 2002; 39(2-3):178-83. PubMed ID: 11921187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice.
    Doi ST; Kimura M; Katsuki M
    Jpn J Cancer Res; 1994 Aug; 85(8):801-7. PubMed ID: 7928625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Ha-ras oncogenes in growth factor independence in rat mammary carcinoma cells.
    Chiodino C; Jones RF; Ethier SP
    Mol Carcinog; 1991; 4(4):286-96. PubMed ID: 1908245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair: counteragent in mutagenesis and carcinogenesis-- accomplice in cancer therapy resistance.
    Rajewsky MF; Engelbergs J; Thomale J; Schweer T
    Mutat Res; 2000 Apr; 462(2-3):101-5. PubMed ID: 10767621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary N-3 fatty acids do not affect induction of Ha-ras mutations in mammary glands of NMU-treated rats.
    Ronai Z; Lau YY; Cohen LA
    Mol Carcinog; 1991; 4(2):120-8. PubMed ID: 2043252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the rat.
    Lu J; Jiang C; Mitrenga T; Cutter G; Thompson HJ
    Carcinogenesis; 1998 Jan; 19(1):223-7. PubMed ID: 9472716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary glands of sexually immature rats are more susceptible than those of mature rats to the carcinogenic, lethal, and mutagenic effects of N-nitroso-N-methylurea.
    Ariazi JL; Haag JD; Lindstrom MJ; Gould MN
    Mol Carcinog; 2005 Jul; 43(3):155-64. PubMed ID: 15924352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
    Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
    Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA adduct formation and molecular analysis of in vivo lacI mutations in the mammary tissue of Big Blue rats treated with 7, 12-dimethylbenz[a]anthracene.
    Manjanatha MG; Shelton SD; Culp SJ; Blankenship LR; Casciano DA
    Carcinogenesis; 2000 Feb; 21(2):265-73. PubMed ID: 10657967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.